Current 10-year atherosclerotic cardiovascular disease risk threshold for statin eligibility is cost-effective for primary prevention.
作者信息
Yeboah Joseph
机构信息
Wake Forest School of Medicine, Winston-Salem, USA.
出版信息
Evid Based Med. 2015 Dec;20(6):230. doi: 10.1136/ebmed-2015-110277. Epub 2015 Sep 2.
PMID:26337629
Abstract
摘要
相似文献
1
Current 10-year atherosclerotic cardiovascular disease risk threshold for statin eligibility is cost-effective for primary prevention.
Evid Based Med. 2015 Dec;20(6):230. doi: 10.1136/ebmed-2015-110277. Epub 2015 Sep 2.
2
Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease.
JAMA. 2015 Jul 14;314(2):142-50. doi: 10.1001/jama.2015.6822.
3
Cost-effectiveness of Statin Therapy for ASCVD.
JAMA. 2015 Nov 24;314(20):2191. doi: 10.1001/jama.2015.12919.
4
Cost-effectiveness of Statin Therapy for ASCVD--Reply.
JAMA. 2015 Nov 24;314(20):2191-2. doi: 10.1001/jama.2015.12928.
5
Use of controversial ACC/AHA guidelines for statin therapy is supported by US studies.
BMJ. 2015 Jul 19;351:h3902. doi: 10.1136/bmj.h3902.
6
Cholesterol Lowering in 2015: Still Answering Questions About How and in Whom.
JAMA. 2015 Jul 14;314(2):127-8. doi: 10.1001/jama.2015.7434.
7
Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis.
PLoS One. 2021 Sep 9;16(9):e0256926. doi: 10.1371/journal.pone.0256926. eCollection 2021.
8
Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Clin Ther. 2009 Dec;31(12):2919-30; discussion 2916-8. doi: 10.1016/j.clinthera.2009.12.013.
9
Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands.
Value Health. 2014 Mar;17(2):223-30. doi: 10.1016/j.jval.2013.12.010.
10
Statins for Primary Prevention of Cardiovascular Disease: Review of Evidence and Recommendations for Clinical Practice.
Med Clin North Am. 2017 Jul;101(4):689-699. doi: 10.1016/j.mcna.2017.03.001.
Zotero 插件